Holen Sie sich die Stockscreener-App
19.84
5.25%
0.99
Handel nachbörslich:
19.82
-0.02
-0.10%
Schlusskurs vom Vortag:
$18.85
Offen:
$18.92
24-Stunden-Volumen:
1.75M
Relative Volume:
1.53
Marktkapitalisierung:
$1.28B
Einnahmen:
$193.35M
Nettoeinkommen (Verlust:
$-177.58M
KGV:
-8.098
EPS:
-2.45
Netto-Cashflow:
$-172.43M
1W Leistung:
+2.59%
1M Leistung:
-5.57%
6M Leistung:
-18.79%
1J Leistung:
-0.35%
1-Tages-Spanne:
$18.90
$19.91
1-Wochen-Bereich:
$18.35
$20.31
52-Wochen-Spanne:
$16.60
$28.47
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Vergleichen Sie SDGR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
19.84 | 1.37B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
279.18 | 45.26B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
69.63 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.27 | 8.00B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Neutral |
| 2022-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-13 | Eingeleitet | Berenberg | Buy |
| 2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-02 | Eingeleitet | Jefferies | Hold |
| 2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
How Investors May Respond To Schrödinger (SDGR) Affirming 2025 Guidance Amid Revenue Growth and Narrowing Losses - simplywall.st
Schrodinger, Inc. Earnings Call: Growth Amid Challenges - TipRanks
What risks could impact Schrödinger Inc. stock performanceMarket Opportunity Tracker for Swing Traders - Newser
Risk adjusted return profile for Schrödinger Inc. analyzedSecure Asset Flow and Trend Pattern Analysis - Newser
Using AI based signals to follow Schrödinger Inc.Strategy Playbook for Risk Controlled Trades - Newser
How to track smart money flows in Schrödinger Inc.Smart Stock Forecast Using AI Algorithms - Newser
Analyzing recovery setups for Schrödinger Inc. investorsStable Swing Setup with Safety Analysis - Newser
Schrödinger maintains 10–15% software revenue growth guidance while advancing SGR-1505 clinical program - MSN
A Quick Look at Today's Ratings for Schrodinger(SDGR.US), With a Forecast Between $30 to $35 - 富途牛牛
Zurcher Kantonalbank Zurich Cantonalbank Sells 538 Shares of Schrodinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger, Inc. Reports Strong Q2 2025 Results - The Globe and Mail
Institutional scanner results for Schrödinger Inc.Free Wealth Building Stock Market Ideas - Newser
Citi Affirms Buy Rating on Schrödinger (SDGR) amid Expanded Collaboration with Ajax Therapeutics - MSN
Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating, Announces Target Price $30 - 富途牛牛
Schrodinger 2025 Q2 Earnings Narrowed Losses with 20.3% EPS Improvement - AInvest
Earnings call transcript: Schrodinger beats Q2 2025 forecasts, stock dips By Investing.com - Investing.com Canada
Earnings call transcript: Schrodinger beats Q2 2025 forecasts, stock dips - Investing.com India
Decoding Schrodinger Inc (SDGR): A Strategic SWOT Insight - GuruFocus
Schrödinger's Dual-Track Strategy: Software Growth and Clinical Pipeline Progress - AInvest
What’s next for Schrödinger Inc. stock priceShort-Term AI-Based Stock Price Forecast - Newser
Schrödinger's Q2 2025: Unpacking Contradictions in Customer Engagement, Toxicology Feedback, and Revenue Confidence - AInvest
Transcript : Schrödinger, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Schrödinger, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:SDGR) - Seeking Alpha
Schrödinger (SDGR) Q2 2025 Earnings Transcript - Mitrade
Schrodinger, Inc. (SDGR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Schrodinger Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Schrödinger Q2 2025 slides: Revenue grows 16% as company maintains full-year guidance - Investing.com Nigeria
Schrödinger Q2 2025 slides: Revenue grows 16% as company maintains full-year guidance By Investing.com - Investing.com South Africa
Schrodinger earnings beat by $0.15, revenue topped estimates - Investing.com India
Schrodinger Inc (SDGR) Q2 2025 Earnings: EPS of -$0.59 Beats Estimate, Revenue Surpasses Forecast at $54.8 Million - GuruFocus
Science and tech firm Schrodinger Q2 revenue beats expectations - MarketScreener
Schrödinger Reports Second Quarter 2025 Financial Results - Yahoo Finance
Why Opendoor Technologies Stock Was Tumbling Today - The Globe and Mail
Earnings To Watch: Schrodinger Inc (SDGR) Reports Q2 2025 Result - Yahoo Finance
Schrodinger (SDGR) to Release Earnings on Wednesday - Defense World
What drives Schrödinger Inc. stock priceInvest smarter with real-time trading alerts - Jammu Links News
What are the technical indicators suggesting about Schrödinger Inc.Get real-time updates on market trends - Jammu Links News
Does Schrödinger Inc. stock perform well during market downturnsBuild a winning investment strategy - Jammu Links News
How volatile is Schrödinger Inc. stock compared to the marketGet exclusive access to expert stock recommendations - Jammu Links News
What catalysts could drive Schrödinger Inc. stock higher in 2025Record-breaking capital gains - Jammu Links News
Is Schrödinger Inc. a good long term investmentTriple-digit growth rates - Jammu Links News
When is Schrödinger Inc. stock expected to show significant growthBreakout profit opportunities - Jammu Links News
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition? - TradingView
Is Opendoor Technologies a Millionaire-Maker Stock? - The Globe and Mail
Financial Review: Schrodinger (NASDAQ:SDGR) & Bullfrog AI (NASDAQ:BFRG) - Defense World
Will Schrödinger Inc. outperform the marketGrowth Focused Entry Plan Suggestions Issued - metal.it
Live Scanner Shows Breakout on Schrödinger Inc.Low Risk Picks for Daily Trading Released - metal.it
Is Schrödinger's (SDGR) Expanded Ajax Partnership Shaping Its Drug Discovery Revenue Potential? - simplywall.st
Screener Results Flag Schrödinger Inc. as OversoldTarget Return Focused Trade Insights Shared - beatles.ru
Is Schrödinger Inc. stock overvalued or undervaluedUnlock steady growth with low-risk stocks - Jammu Links News
Schrodinger SDGR Q2 2025 Earnings Preview Upside Potential on Strong Software Revenue Growth - AInvest
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Schrodinger Inc-Aktie (SDGR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Akinsanya Karen | President of R&D, Therapeutics |
Apr 14 '25 |
Sale |
25.09 |
16,723 |
419,570 |
15,625 |
11.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):